Hypoglycemia

Children and adults with type 1 diabetes assigned to an artificial pancreas for 6 months spent an average of 2.6 fewer hours per day in hyperglycemia and 13 fewer minutes per day in hypoglycemia when compared with participants using sensor-augmented insulin pump therapy, according to findings published in The New England Journal of Medicine.

Adults with insulin-dependent type 2 diabetes assigned to insulin degludec for up to 88 weeks experienced fewer severe or confirmed symptomatic hypoglycemia episodes during a maintenance phase when compared with similar adults assigned to insulin glargine 300 u/mL; however, researchers cautioned that several factors complicate the data, according to analyses from the CONCLUDE trial presented at the European Association for the Study of Diabetes annual meeting.

An international survey of more than 4,300 family members of people with diabetes suggests that most feel worried or anxious about their loved one experiencing a hypoglycemic episode, with three-quarters of respondents reporting they spent time helping family members manage low blood glucose events, according to findings published in Diabetes Therapy.

The FDA on Tuesday approved the GVOKE glucagon injection system, which features a liquid glucagon formulation that is stable at room temperature, for treatment of severe episodes of hypoglycemia among adults and children older than 2 years with type 2 diabetes, according to a press release from Xeris Pharmaceuticals.

The top stories in endocrinology last week included a speaker at the American Association of Diabetes Educators annual meeting who suggested that health care providers revise diabetes medication regimens for patients who adopt a ketogenic or low-carb diet. In other news, a study that found the use of intensive glucose-lowering agents to treat patients with diabetes may be leading to more instances of hypoglycemia that require hospital and ED visits.

Children with diabetes and their families are seeing improved health outcomes and better quality of life as they adopt newer diabetes technologies. However, the schools in which these children spend a substantial portion of their day are often under-resourced and under-informed about technology.

Use of intensive glucose-lowering agents to treat patients with diabetes and lower HbA1c may be leading to more instances of hypoglycemia that require hospital and emergency department visits, according to findings published in Mayo Clinic Proceedings.

HOUSTON — Assessment of hypoglycemia is critical at every appointment for a person with diabetes, and there are several important steps diabetes care and education specialists can take help prevent dangerously low blood glucose, according to two speakers at the American Association of Diabetes Educators annual meeting.

HOUSTON — Remote monitoring of pregnant women with diabetes via a smart glucose meter increased patient engagement with diabetes care and education specialists and better informed treatment decisions, according to study data presented at the American Association of Diabetes Educators annual meeting.

HOUSTON — Machine learning has immense potential for improving diabetes care, particularly when used by diabetes care and education specialists, according to two presenters at the American Association of Diabetes Educators annual meeting.